Dagmar Fischer

Title: Dagmar Fischer: Innovator in Biologically Tolerated Polyethylenimines

Introduction

Dagmar Fischer is a prominent inventor based in Marburg, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of low molecular weight polyethylenimines. Her work focuses on creating vectors for inserting nucleic acids into cells, which has important implications for gene therapy and biotechnology.

Latest Patents

Dagmar Fischer holds 1 patent for her invention titled "Biologically tolerated low molecular weight polyethylenimines." This invention relates to low molecular weight polyethylenimines and their use as vectors for inserting nucleic acids into cells. The patent details the preparation and application of these polyethylenimines, which have a molecular weight of less than 50,000 Da, making them suitable for various biomedical applications.

Career Highlights

Fischer is currently associated with Sanofi-Aventis Deutschland GmbH, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of polyethylenimines in the medical field.

Collaborations

Throughout her career, Dagmar Fischer has collaborated with notable colleagues, including Thomas Kissel and Hans-Peter Elsässer. These collaborations have enriched her research and contributed to the success of her innovations.

Conclusion

Dagmar Fischer's contributions to the field of biochemistry, particularly through her patent on low molecular weight polyethylenimines, highlight her role as an influential inventor. Her work continues to pave the way for advancements in gene therapy and biotechnology.